Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance.

After years of calling obesity drug stocks overhyped, a top analyst now sees Novo Nordisk as a big opportunity.

The second group, so-called "Constrained Losers," are those hard-to-short stocks that have lost the most over the trailing year. The professors found that these stocks also lag the market, but for a ...

Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...

Discover the top 3 undervalued Health Care Providers & Services stocks for Thursday, March 13 based on AAII’s Stock Grades.

Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...

2-Year U.S. Treasury Note Continuous Contract $103.535 0.070 0.07% 5-Year U.S. Treasury Note Continuous Contract $107.938 0.211 0.20% 10-Year U.S. Treasury Note Continuous Contract $110.953 0.313 ...